News
-
What Medicaid Changes Mean for Your Patients
The “One Big Beautiful Bill Act” was signed on July 4, 2025, and its Medicaid provisions are now rolling out on a tight timeline. The first major cutoff takes effect October 1, three weeks away. A second wave follows January 1, 2027. Statewide, up to 175,000 Marylanders are projected to lose coverage. At last week’s…
-
What Maryland Physicians Earn and Why the Gender Pay Gap Persists
September is Women in Medicine Month, and it is a good time to look at a number that has not moved much. The physician gender pay gap is not a theoretical problem. In Maryland, it has been measured, published, and largely unchanged for years. Female physicians in this state earn more than 30% less than…
-
MIA/MHBE Joint Meeting to Discuss Assistance to Small Businesses
The Maryland Insurance Administration (MIA) and the Maryland Health Benefit Exchange (MHBE) announce a virtual, open meeting on Thursday, October 1, to discuss how they can support small businesses and employees in navigating health insurance amid recent market changes. The MIA and MHBE invite members of the small business community to join us for an…
-
New Podcast Episode on Maryland’s Healthcare Model
This episode from the Maryland Now podcast explores the history of Maryland’s unique all-payer healthcare system. The episode features insights from healthcare leaders across the state, including Gene Ransom, CEO of MedChi. On this episode, host David Nitkin takes on healthcare – an industry so big and so personal that he almost didn’t tackle it,…
-
Cannabinoids for Chronic Pain
On-demand, 1.0 AMA PRA Category 1 Description This free CME, Cannabinoids for Chronic Pain, was developed in partnership with Med-Chi, the Prescription Drug Monitoring Program (PDMP), the Maryland Cannabis Administration, and Dr. Deondra Asike, a double board-certified anesthesiologist and pain management specialist. Designed to help clinicians navigate the evolving landscape of pain management and state…
-
Written Comment Request- Dupixent and Skyrizi
In accordance with COMAR 14.01.01.05B(4), the Prescription Drug Affordability Board requests public written comment for the cost review study process on: Dupixent (dupilumab) Drug Brand Name: Dupixent Active Moiety or Active Ingredient: dupilumab Application Number: BLA761055 NDC 11s in the Cost Review Study Process AND Skyrizi (risankizumab) Drug Brand Name: Skyrizi Active Moiety or Active…
-
2026-27 Respiratory Season Evidence & Recommendations
On September 2, the American Medical Association (AMA) and the Vaccine Integrity Project (VIP), announced the release of an independent evidence review to inform respiratory virus immunization recommendations for the 2026-27 season. These recommendations were developed by: American Academy of Pediatrics (<19 years of age) American Academy of Family Physicians (≥19 years of age and health care personnel)…
-
Can Methadone be Effectively Provided in Primary Care?
New and old evidence from abroad says yes.The US would need a system overturn. Jasleen Salwan M.D., M.P.H., F.A.S.A.M. Key points In the US, methadone treatment for opioid addiction is only available through specialty clinics. Other countries allow primary care providers to prescribe methadone, to be dispensed at community pharmacies. A new study from Ukraine…
-
This September, Recovery Happens Together in Montgomery County
September is National Recovery Month, established in 1989 to promote evidence-based treatment and recovery practices and to celebrate the millions of Americans who are living in recovery from substance use disorders. The 2026 campaign carries the theme that recovery from addiction happens together, with SAMHSA framing meaningful human connection as central to resilience and long-term…
-
Members in the News: Harita Raja, M.D.
MCMS member Harita Raja, M.D., was honored as one of only six “women who inspire” in Montgomery County by Bethesda Magazine. You can read the full article here.
